Cape Verde vs Kenya: The number of people with susceptibility test result for rifampicin
Cape Verde
69.01
in 2021
Kenya
63.13
in 2021
Cape Verde rank
105th
Kenya rank
107th
The number of people with susceptibility test result for rifampicin over time
- Cape Verde
- Kenya
How they compare
Cape Verde currently reports 69.01 against 63.13 in Kenya, a difference of 5.88.
That makes Cape Verde's figure about 1.1 times Kenya's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Kenya ahead.
Cape Verde ranks 105th and Kenya ranks 107th of 146 countries.
Kenya has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cape Verde | Kenya | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.97 | 68.03 | 11.06 | Kenya |
| 2020s | 60 | 74.02 | 14.01 | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cape Verde or Kenya?
- Cape Verde, at 69.01 against 63.13 in Kenya as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cape Verde and Kenya?
- 5.88, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Kenya?
- 5 years are reported by both, from 2017 to 2021.
- How do Cape Verde and Kenya rank globally for the number of people with susceptibility test result for rifampicin?
- Cape Verde ranks 105th and Kenya ranks 107th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.